Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Aria F Olumi"'
Autor:
Zongwei Wang, Tuo Deng, Xingbo Long, Xueming Lin, Shulin Wu, Hongbo Wang, Rongbin Ge, Zhenwei Zhang, Chin-Lee Wu, Mary-Ellen Taplin, Aria F Olumi
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229754 (2020)
PURPOSE:To determine whether SRD5A2 promoter methylation is associated with cancer progression during androgen deprivation therapy (ADT) in CRPC. PATIENTS AND METHODS:In a Local CRPC cohort, 42 prostatic specimens were collected from patients who wer
Externí odkaz:
https://doaj.org/article/104f90a3732d489c8d1365e8d4363a94
Autor:
Zongwei Wang, Xingyuan Xiao, Rongbin Ge, Jijun Li, Cameron W Johnson, Cyrus Rassoulian, Aria F Olumi
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173335 (2017)
OBJECTIVE:Benign prostatic hyperplasia (BPH) is the most common proliferative abnormality of the prostate affecting elderly men throughout the world. Epidemiologic studies have shown that diabetes significantly increases the risk of developing BPH, a
Externí odkaz:
https://doaj.org/article/9e4a523be2464663858db85e845f5e3d
Autor:
Zhipeng Tao, Limin Shi, Jane Parke, Louise Zheng, Wei Gu, X. Charlie Dong, Dongmin Liu, Zongwei Wang, Aria F. Olumi, Zhiyong Cheng
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/7e7df97caa704a9e81c0107c0cc70733
Autor:
John Ernandez, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Simon Kim, Joaquim Bellmunt, Irving Kaplan, Aria F. Olumi, Boris Gershman
Publikováno v:
Bladder Cancer. 8:405-417
BACKGROUND: Survival with locally advanced bladder cancer (LABC) following radical cystectomy (RC) remains poor. Although adjuvant chemotherapy (AC) is standard of care, one small, randomized trial has suggested a potential survival benefit when comb
Publikováno v:
Journal of Urology. 209
Publikováno v:
Journal of Urology. 209
Publikováno v:
Journal of Urology. 209
Publikováno v:
Journal of Urology. 209
Purpose: Previously, we have shown that c-Fos/activator protein-1 (AP-1) promotes tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL)–induced apoptosis by repressing the antiapoptotic molecule c-FLIP(L). In this study, we invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1796e899a9232d3e03ee5e464a10da5f
https://doi.org/10.1158/1078-0432.c.6518751.v1
https://doi.org/10.1158/1078-0432.c.6518751.v1
Autor:
Gregory Stephanopoulos, Matthew G. Vander Heiden, Aria F. Olumi, Michael N. Pollak, John Blenis, Leonard Guarente, Lewis C. Cantley, Marie Jose Blouin, Akash Patnaik, Alfredo Csibi, Gary Bellinger, Matthias Schwab, Jared R. Mayers, Brian Fiske, Gregory J. Wirth, Shawn M. Davidson, Mark A. Keibler, Eric L. Bell, Sarah-Maria Fendt
Metformin inhibits cancer cell proliferation, and epidemiology studies suggest an association with increased survival in patients with cancer taking metformin; however, the mechanism by which metformin improves cancer outcomes remains controversial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4536ff225804a4ce53cfb8506478efac
https://doi.org/10.1158/0008-5472.c.6504660.v1
https://doi.org/10.1158/0008-5472.c.6504660.v1